Literature DB >> 28485125

An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS).

Elena Deligianni1, John M Corkery1, Fabrizio Schifano1, Lisa A Lione1.   

Abstract

OBJECTIVE: This survey investigated the level of public awareness, preference, and motivation of novel psychoactive substances (NPS) use as well as knowledge of potential associated health risks.
METHODS: A Bristol Online Survey was advertised through social media and a drug forum "Bluelight" between January 7 and February 7, 2015.
RESULTS: Responses were received from 17 countries, mainly from Europe. Most responses (83%) came from university educated students. Two-thirds (65%) of the 168 respondents were aware of NPS. Awareness was significantly increased in those with bisexual or homosexual orientation (p < .05) and those in employment (p < .05). Fourteen percent of the 168 respondents were users of NPS, and use was significantly affected by age and employment (p < .01) but unaffected by level of education (p > .05). Nearly half of the NPS users perceived NPS to carry either a low risk to health (20%) or did not know whether or not they posed a health risk (29%).
CONCLUSIONS: These survey data indicate that awareness of NPS and, importantly, perception of the potential health risks associated with NPS use is lacking. NPS awareness and use is higher in those in employment but is unaffected by level of education. This highlights the need for targeted drugs education intervention by policy-makers in schools and universities.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ketamine; novel psychoactive substances (NPS); online survey; psychoactive effects; recreational use; ‘legal high’

Mesh:

Substances:

Year:  2017        PMID: 28485125     DOI: 10.1002/hup.2581

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  4 in total

1.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

2.  Awareness of users and motivational factors for using new psychoactive substances in Belgium.

Authors:  Sarah Simonis; Michaël Canfyn; Anton Van Dijck; Tina Van Havere; Eric Deconinck; Peter Blanckaert; Lies Gremeaux
Journal:  Harm Reduct J       Date:  2020-07-25

3.  Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study.

Authors:  Suzanne K Vosburg; Taryn Dailey-Govoni; Jared Beaumont; Stephen F Butler; Jody L Green
Journal:  JMIR Form Res       Date:  2022-06-10

4.  Social media recruitment for mental health research: A systematic review.

Authors:  Catherine Sanchez; Adrienne Grzenda; Andrea Varias; Alik S Widge; Linda L Carpenter; William M McDonald; Charles B Nemeroff; Ned H Kalin; Glenn Martin; Mauricio Tohen; Maria Filippou-Frye; Drew Ramsey; Eleni Linos; Christina Mangurian; Carolyn I Rodriguez
Journal:  Compr Psychiatry       Date:  2020-08-12       Impact factor: 3.735

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.